CD274 and neoplasm: Programmed death-ligand 1 (PD-L1) expression22,23,28,29 and microsatellite instability (MSI)28,30 are used as companion diagnostic markers; tumour mutation burden (TMB) is also one of the potential biomarkers of ICI response28,29,31.